144 related articles for article (PubMed ID: 38294896)
1. Economic burden of COVID-19 for employers and employees in the United States.
Sell H; Schaible K; Gouveia-Pisano JA; Yehoshua A; Malhotra D; Di Fusco M; Cha-Silva AS; Andersen KM; Nicholls L; Landi SN; Rolland C; Judy J
J Med Econ; 2024; 27(1):267-278. PubMed ID: 38294896
[TBL] [Abstract][Full Text] [Related]
2. Economic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study.
Hu T; Miles AC; Pond T; Boikos C; Maleki F; Alfred T; Lopez SMC; McGrath L
J Med Econ; 2024; 27(1):324-336. PubMed ID: 38343288
[TBL] [Abstract][Full Text] [Related]
3. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
[TBL] [Abstract][Full Text] [Related]
4. Impact of Influenza and Influenza-Like Illness on Work Productivity Outcomes: A Systematic Literature Review.
Blanchet Zumofen MH; Frimpter J; Hansen SA
Pharmacoeconomics; 2023 Mar; 41(3):253-273. PubMed ID: 36515814
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. The impact of vaccination and outpatient treatment on the economic burden of Covid-19 in the United States omicron era: a systematic literature review.
Pierre V; Draica F; Di Fusco M; Yang J; Nunez-Gonzalez S; Kamar J; Lopez S; Moran MM; Nguyen J; Alvarez P; Cha-Silva A; Gavaghan M; Yehoshua A; Stapleton N; Burnett H
J Med Econ; 2023; 26(1):1519-1531. PubMed ID: 37964554
[TBL] [Abstract][Full Text] [Related]
7. Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.
Parasuraman S; Thiel E; Park J; Teschemaker A
J Med Econ; 2023; 26(1):454-462. PubMed ID: 36883994
[TBL] [Abstract][Full Text] [Related]
8. Association of health care utilization and costs with patient-reported outcomes in patients with ankylosing spondylitis.
Ogdie A; Hwang M; Veeranki P; Portelli A; Sison S; Shafrin J; Pedro S; Kim N; Yi E; Michaud K
J Manag Care Spec Pharm; 2022 Sep; 28(9):1008-1020. PubMed ID: 36001102
[No Abstract] [Full Text] [Related]
9. Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study.
Allen D; Hines EW; Pazdernik V; Konecny LT; Breitenbach E
Hum Resour Health; 2018 Nov; 16(1):59. PubMed ID: 30413168
[TBL] [Abstract][Full Text] [Related]
10. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
[No Abstract] [Full Text] [Related]
11. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
12. Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study.
Ketkar A; Willey V; Pollack M; Glasser L; Dobie C; Wenziger C; Teng CC; Dube C; Cunningham D; Verduzco-Gutierrez M
Curr Med Res Opin; 2023 Aug; 39(8):1103-1118. PubMed ID: 37431293
[TBL] [Abstract][Full Text] [Related]
13. Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed in outpatient settings in the United States.
Scott A; Chambers R; Reimbaeva M; Atwell J; Baillon-Plot N; Draica F; Tarallo M
J Med Econ; 2022; 25(1):287-298. PubMed ID: 35114896
[TBL] [Abstract][Full Text] [Related]
14. The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review.
Witkowski M; Moreno SI; Fernandes J; Johansen P; Augusto M; Nair S
Pharmacoeconomics; 2022 Aug; 40(8):751-776. PubMed ID: 35789987
[TBL] [Abstract][Full Text] [Related]
15. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
[TBL] [Abstract][Full Text] [Related]
16. Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United States.
Zhang X; Beachler DC; Masters E; Liu F; Yang M; Dinh J; Jamal-Allial A; Kolitsopoulos F; Lamy FX
J Manag Care Spec Pharm; 2022 Feb; 28(2):255-265. PubMed ID: 34854733
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
